Jula Inrig is CMO & VP at Travere Therapeutics, Inc. (TVTX). They have made 4 open-market trades across 1 company since 2023, most recently 2026-09-15.
CIK 0001902368
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TVTX | 100,491 | $5.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVTX | SELL · 10b5-1 | 2026-09-15 | 2026-09-17 | $62.34 | $2.8M | -7.0% | — | — |
| TVTX | SELL · 10b5-1 | 2026-05-04 | 2026-05-06 | $45.15 | $1.0M | -5.7% | +0.6% | +23.2% |
| TVTX | SELL · 10b5-1 | 2026-04-14 | 2026-04-15 | $42.01 | $346K | +2.5% | +6.9% | +43.3% |
| TVTX | SELL · 10b5-1 | 2026-02-04 | 2026-02-05 | $32.21 | $57K | -6.8% | -3.1% | +49.6% |
| TVTX | SELL | 2026-02-03 | 2026-02-03 | $32.12 | $223K | -15.2% | -16.7% | +37.0% |
| TVTX | SELL · 10b5-1 | 2026-01-05 | 2026-01-07 | $39.74 | $98K | -22.2% | -17.2% | -11.8% |
| TVTX | SELL · 10b5-1 | 2025-12-24 | 2025-12-29 | $42.00 | $630K | -10.4% | -21.6% | -28.4% |
| TVTX | SELL · 10b5-1 | 2025-07-01 | 2025-07-02 | $14.65 | $12K | +10.2% | +5.2% | +60.8% |
| TVTX | SELL | 2025-02-12 | 2025-02-12 | $23.53 | $121K | -10.5% | -14.4% | -9.2% |
| TVTX | SELL · 10b5-1 | 2025-02-03 | 2025-02-04 | $20.12 | $191K | +8.8% | -10.1% | +1.7% |
| TVTX | SELL · 10b5-1 | 2025-01-03 | 2025-01-06 | $19.04 | $48K | -1.9% | +13.3% | -19.0% |
| TVTX | SELL · 10b5-1 | 2024-09-10 | 2024-09-10 | $12.98 | $9K | +20.0% | +34.9% | +48.0% |
| TVTX | SELL | 2024-09-09 | 2024-09-09 | $11.52 | $25K | +16.7% | +36.4% | +45.5% |
| TVTX | SELL | 2024-02-01 | 2024-02-02 | $8.53 | $19K | -0.8% | -1.6% | -26.0% |
| TVTX | SELL · 10b5-1 | 2024-01-03 | 2024-01-05 | $9.43 | $24K | +5.7% | -1.7% | -17.3% |
| TVTX | SELL · 10b5-1 | 2023-01-04 | 2023-01-06 | $20.75 | $52K | +5.7% | +10.1% | +4.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.